Alvotech
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Alvotech now
Current reporting with the operating signal separated from the noise.
Alvotech (NASDAQ:ALVO) Shares Down 6.7% - Time to Sell?
Investors are testing whether Alvotech’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Novo misses, AstraZeneca holds steady, Alvotech clears FDA – the Nordic Pulse | 2026:31
The story matters when it changes Alvotech’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Alvotech (ALVO) Is Up 34.6% After FDA Clears Reykjavik Plant And BLAs Advance - Has The Bull Case Changed?
The story matters when it changes Alvotech’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Alvotech SA (ALVO) Financial Health: Profitability & Balance Sheet Analysis
Investors are testing whether Alvotech’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Alvotech $ALVO Shares Sold by Oaktree Capital Management LP
Investors are testing whether Alvotech’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Alvotech (NASDAQ:ALVO) Given Consensus Rating of "Hold" by Brokerages
The story matters when it changes Alvotech’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Alvotech Shares Rise After Wrapping FDA Facility Inspection
Investors are testing whether Alvotech’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Alvotech (NASDAQ:ALVO) Shares Up 13.5% - Here's What Happened
Investors are testing whether Alvotech’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Alvotech Gains FDA VAI Rating as Reykjavik Biosimilar Plant Clears Inspection
The development tests whether Alvotech can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.FDA closes Alvotech (NASDAQ: ALVO) Iceland plant inspection with VAI status
The development tests whether Alvotech can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.US FDA Closes Inspection of Alvotech's Manufacturing Facility in Iceland
The story matters when it changes Alvotech’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Alvotech clears FDA inspection of Iceland manuf...
The story matters when it changes Alvotech’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ALVO filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Alvotech, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →